LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 67

Search options

  1. Article: Sessile serrated polyp detection rates after fecal immunochemical test or multitarget stool DNA test: Systematic review and meta-analysis.

    Garg, Rajat / Burke, Carol A / Aggarwal, Manik / Macaron, Carole / Singh, Amandeep / Kim, Michelle K / Regueiro, Miguel / Amit, Bhatt / Chahal, Prabhleen / Garg, Shashank

    Endoscopy international open

    2024  Volume 12, Issue 4, Page(s) E474–E487

    Abstract: Background and study ... ...

    Abstract Background and study aims
    Language English
    Publishing date 2024-04-05
    Publishing country Germany
    Document type Journal Article ; Review
    ZDB-ID 2761052-4
    ISSN 2196-9736 ; 2364-3722
    ISSN (online) 2196-9736
    ISSN 2364-3722
    DOI 10.1055/a-2256-3411
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Efficacy and safety of double- versus single-balloon retrograde enteroscopy.

    Garg, Rajat / Singh, Amandeep / Mohammed, Abdul / Aggarwal, Manik / Stevens, Tyler / Vargo, John / Jang, Sunguk

    European journal of gastroenterology & hepatology

    2023  Volume 35, Issue 4, Page(s) 365–370

    Abstract: Introduction: Data on the safety and efficacy of double-balloon enteroscopy (DBE) and single-balloon enteroscopy (SBE) are conflicting. We aimed to compare the efficacy and safety of retrograde DBE to SBE.: Methods: We performed a retrospective ... ...

    Abstract Introduction: Data on the safety and efficacy of double-balloon enteroscopy (DBE) and single-balloon enteroscopy (SBE) are conflicting. We aimed to compare the efficacy and safety of retrograde DBE to SBE.
    Methods: We performed a retrospective analysis of all patients who underwent retrograde DBE or SBE at a large tertiary referral center from 2008 to December 2018. Outcomes assessed included technical success, diagnostic yield, therapeutics, depth of insertion, and procedural duration.
    Results: A total of 523 (403 DBE, 120 SBE) patients underwent retrograde enteroscopy during the study period. The mean age was 59.4 ± 17.24 and 59.57 ± 16.94 years in DBE and SBE groups, respectively. There was no difference in technical success (91.0% vs. 92.5%, P = 0.85), diagnostic yield (40.9% vs. 40.8%, P = 0.95), and therapeutics (17.1% vs. 19.1%, P = 0.61) between DBE and SBE. Compared to SBE, DBE had significantly shorter mean procedure time (26.5 ± 34.5 min vs. 34.8 ± 29.4 min, P = 0.01) and higher maximal depth of insertion from ileocecal valve (108.1 ± 84.1 cm vs. 73.3 ± 63.4 cm, P = 0.001). Safety events were rare and similar in both groups.
    Conclusion: Retrograde DBE is associated with a significantly higher depth of insertion and shorter procedural duration, but similar diagnostic yield and technical success compared to SBE.
    MeSH term(s) Humans ; Adult ; Middle Aged ; Aged ; Retrospective Studies ; Intestine, Small ; Single-Balloon Enteroscopy ; Double-Balloon Enteroscopy ; Time Factors ; Intestinal Diseases/diagnosis
    Language English
    Publishing date 2023-02-13
    Publishing country England
    Document type Journal Article
    ZDB-ID 1034239-4
    ISSN 1473-5687 ; 0954-691X
    ISSN (online) 1473-5687
    ISSN 0954-691X
    DOI 10.1097/MEG.0000000000002522
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article: Natural history of gastrointestinal schwannomas.

    Singh, Amandeep / Aggarwal, Manik / Chadalavada, Pravallika / Siddiqui, Mohamed Tausif / Garg, Rajat / Lai, Keith / Chahal, Prabhleen

    Endoscopy international open

    2022  Volume 10, Issue 6, Page(s) E801–E808

    Abstract: Background and study ... ...

    Abstract Background and study aims
    Language English
    Publishing date 2022-06-10
    Publishing country Germany
    Document type Journal Article
    ZDB-ID 2761052-4
    ISSN 2196-9736 ; 2364-3722
    ISSN (online) 2196-9736
    ISSN 2364-3722
    DOI 10.1055/a-1784-0806
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Post-pancreatitis diabetes mellitus: insight on optimal management with nutrition and lifestyle approaches.

    Singh, Amandeep / Aggarwal, Manik / Garg, Rajat / Stevens, Tyler / Chahal, Prabhleen

    Annals of medicine

    2022  Volume 54, Issue 1, Page(s) 1776–1786

    Abstract: Pancreatitis is the leading gastrointestinal cause of hospitalizations. There are multiple short- and long-term complications associated with pancreatitis. Post-pancreatitis diabetes mellitus (PPDM) is one of the less explored complications of ... ...

    Abstract Pancreatitis is the leading gastrointestinal cause of hospitalizations. There are multiple short- and long-term complications associated with pancreatitis. Post-pancreatitis diabetes mellitus (PPDM) is one of the less explored complications of pancreatitis. Nonetheless, it has attracted considerable attention during the last decade. PPDM is now the second most common cause of new-onset diabetes mellitus (DM) in adults after type II DM surpassing type 1 DM. However, there exists a knowledge gap amongst practitioners regarding diagnosis, complications, and management of PPDM. In this narrative, we aim to provide a brief review regarding risks, diagnosis and management of PPDM with a special focus on dietary and lifestyle management strategies.KEY MESSAGESPost-pancreatitis diabetes mellitus (PPDM) is now the second most common cause of new-onset diabetes mellitus (DM) in adults after type II DM surpassing type 1 DM.New-onset diabetes in patients with pancreatitis could also be an early marker of occult pancreatic malignancy.Management of PPDM is complex and requires a team-based approach including gastroenterologists, endocrinologists, primary care physicians, nutritionists, and behavioural health specialists.
    MeSH term(s) Adult ; Diabetes Mellitus, Type 2/complications ; Diabetes Mellitus, Type 2/therapy ; Hospitalization ; Humans ; Life Style ; Pancreatitis/complications ; Pancreatitis/therapy
    Language English
    Publishing date 2022-07-02
    Publishing country England
    Document type Journal Article ; Review
    ZDB-ID 1004226-x
    ISSN 1365-2060 ; 1651-2219 ; 0785-3890 ; 1743-1387
    ISSN (online) 1365-2060 ; 1651-2219
    ISSN 0785-3890 ; 1743-1387
    DOI 10.1080/07853890.2022.2090601
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Post-pancreatitis diabetes mellitus

    Amandeep Singh / Manik Aggarwal / Rajat Garg / Tyler Stevens / Prabhleen Chahal

    Annals of Medicine, Vol 54, Iss 1, Pp 1776-

    insight on optimal management with nutrition and lifestyle approaches

    2022  Volume 1786

    Abstract: Pancreatitis is the leading gastrointestinal cause of hospitalizations. There are multiple short- and long-term complications associated with pancreatitis. Post-pancreatitis diabetes mellitus (PPDM) is one of the less explored complications of ... ...

    Abstract Pancreatitis is the leading gastrointestinal cause of hospitalizations. There are multiple short- and long-term complications associated with pancreatitis. Post-pancreatitis diabetes mellitus (PPDM) is one of the less explored complications of pancreatitis. Nonetheless, it has attracted considerable attention during the last decade. PPDM is now the second most common cause of new-onset diabetes mellitus (DM) in adults after type II DM surpassing type 1 DM. However, there exists a knowledge gap amongst practitioners regarding diagnosis, complications, and management of PPDM. In this narrative, we aim to provide a brief review regarding risks, diagnosis and management of PPDM with a special focus on dietary and lifestyle management strategies.KEY MESSAGESPost-pancreatitis diabetes mellitus (PPDM) is now the second most common cause of new-onset diabetes mellitus (DM) in adults after type II DM surpassing type 1 DM.New-onset diabetes in patients with pancreatitis could also be an early marker of occult pancreatic malignancy.Management of PPDM is complex and requires a team-based approach including gastroenterologists, endocrinologists, primary care physicians, nutritionists, and behavioural health specialists.
    Keywords Post-pancreatitis diabetes ; diet ; nutrition ; management ; Medicine ; R
    Subject code 571
    Language English
    Publishing date 2022-12-01T00:00:00Z
    Publisher Taylor & Francis Group
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  6. Article ; Online: Trends and outcomes of infective endocarditis in cirrhosis: a propensity-matched national study.

    Garg, Rajat / Aggarwal, Manik / Ahuja, Keerat R / Singh, Amandeep / Sanaka, Madhusudan R / McCullough, Arthur

    European journal of gastroenterology & hepatology

    2022  Volume 33, Issue 1S Suppl 1, Page(s) e580–e586

    Abstract: Background: Cirrhosis is the most common cause of liver-related death and bacterial infection is a common comorbidity in cirrhosis. We aimed to study the trends and outcomes of infective endocarditis in cirrhosis.: Methods: A propensity-matched ... ...

    Abstract Background: Cirrhosis is the most common cause of liver-related death and bacterial infection is a common comorbidity in cirrhosis. We aimed to study the trends and outcomes of infective endocarditis in cirrhosis.
    Methods: A propensity-matched analysis of the National Inpatient Sample database was performed to assess outcomes of infective endocarditis in adult patients (>18 years) from 2004-2013 with and without cirrhosis. Various outcomes were assessed for outcomes of infective endocarditis in cirrhosis. Multivariate regression analysis was performed for predictors of mortality in infective endocarditis.
    Results: There has been no significant change in incidence (3.3-3.6%, P = 0.27) and overall mortality (6.3-8.6%, P = 0.42) of infective endocarditis in cirrhosis. After propensity matching, patients with cirrhosis had significantly higher in-hospital mortality (15 vs. 10.6%, P < 0.001) and acute kidney injury (AKI) (31.8 vs. 28.5%, P < 0.001) as compared to no cirrhosis. Microbiological analysis revealed significantly higher rates of streptococci (35.3 vs. 31.9%, P < 0.001) and fungal infective endocarditis (0.03 vs. 0%, P < 0.001) and lower incidence of Gram-negative infective endocarditis (3.9 vs. 6.3%, P < 0.001) in cirrhosis. Cirrhosis patients had significantly less surgical intervention (10.2 vs. 30.3%, P < 0.001) along with overall total cost and length of stay as compared to no cirrhosis. On multivariate analysis, advanced age, AKI, shock and mechanical ventilation were positive predictors of mortality in infective endocarditis patients with cirrhosis patients.
    Conclusions: Cirrhosis is an independent predictor of mortality in infective endocarditis with worse outcomes and less surgical intervention. Gram-negative infective endocarditis is lower in cirrhosis, whereas streptococci and fungal infective endocarditis are higher than noncirrhotic patients.
    MeSH term(s) Acute Kidney Injury ; Adult ; Endocarditis/diagnosis ; Endocarditis/epidemiology ; Endocarditis/therapy ; Endocarditis, Bacterial/diagnosis ; Endocarditis, Bacterial/epidemiology ; Endocarditis, Bacterial/therapy ; Hospital Mortality ; Humans ; Liver Cirrhosis/complications ; Liver Cirrhosis/diagnosis ; Liver Cirrhosis/epidemiology ; Retrospective Studies ; Risk Factors
    Language English
    Publishing date 2022-01-20
    Publishing country England
    Document type Journal Article
    ZDB-ID 1034239-4
    ISSN 1473-5687 ; 0954-691X
    ISSN (online) 1473-5687
    ISSN 0954-691X
    DOI 10.1097/MEG.0000000000002177
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Development of machine learning model to detect fibrotic non-alcoholic steatohepatitis in patients with non-alcoholic fatty liver disease.

    Aggarwal, Manik / Rozenbaum, Daniel / Bansal, Agam / Garg, Rajat / Bansal, Parikshit / McCullough, Arthur

    Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

    2021  Volume 53, Issue 12, Page(s) 1669–1672

    MeSH term(s) Adult ; Cross-Sectional Studies ; Female ; Fibrosis ; Humans ; Machine Learning ; Male ; Middle Aged ; Non-alcoholic Fatty Liver Disease/diagnosis ; Non-alcoholic Fatty Liver Disease/epidemiology ; Non-alcoholic Fatty Liver Disease/pathology
    Language English
    Publishing date 2021-08-13
    Publishing country Netherlands
    Document type Letter
    ZDB-ID 1459373-7
    ISSN 1878-3562 ; 1125-8055
    ISSN (online) 1878-3562
    ISSN 1125-8055
    DOI 10.1016/j.dld.2021.07.016
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Efficacy and Safety of Azilsartan Medoxomil and Telmisartan in Hypertensive Patients: A Randomized, Assessor-Blinded Study.

    Garg, Megha / Manik, Geetesh / Singhal, Alok / Singh, V K / Varshney, Rohit K / Sethi, Aseem

    Saudi journal of medicine & medical sciences

    2020  Volume 8, Issue 2, Page(s) 87–94

    Abstract: Background: Few studies have compared the safety and efficacy of azilsartan medoxomil (AZL-M) and telmisartan in hypertensive patients, especially using ambulatory blood pressure monitoring (ABPM).: Objective: The objective of this study was to ... ...

    Abstract Background: Few studies have compared the safety and efficacy of azilsartan medoxomil (AZL-M) and telmisartan in hypertensive patients, especially using ambulatory blood pressure monitoring (ABPM).
    Objective: The objective of this study was to compare the efficacy and safety profile of AZL-M and telmisartan in hypertensive patients using ABPM and clinic blood pressure (BP) monitoring.
    Materials and methods: This prospective, randomized, open-label, blinded endpoint, parallel-arm study included 700 patients, aged 18-70 years, with clinic and 24-h mean ambulatory systolic BP (SBP) of 150-180 mmHg and 130-170 mmHg, respectively. They were randomized equally into two groups: Group A received AZL-M 40 mg and Group T received telmisartan 40 mg; the dose was force titrated to 80 mg after 2 weeks if the response rate was not achieved. BP (clinical and ambulatory) was measured after 12 weeks and compared with baseline measurements.
    Results: AZL-M significantly reduced the 24-h mean ambulatory SBP (Group A: 112.74 ± 7.58 mmHg; Group T: 113.96 ± 8.52 mmHg;
    Conclusion: This study found that AZL-M has greater antihypertensive efficacy than telmisartan, with comparable side effects. In addition, ABPM was shown to be a feasible method for such studies.
    Language English
    Publishing date 2020-04-17
    Publishing country India
    Document type Journal Article
    ZDB-ID 2734896-9
    ISSN 2321-4856 ; 2321-4856
    ISSN (online) 2321-4856
    ISSN 2321-4856
    DOI 10.4103/sjmms.sjmms_19_19
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Meta-analysis of COVID-19 single-cell studies confirms eight key immune responses

    Manik Garg / Xu Li / Pablo Moreno / Irene Papatheodorou / Yuelong Shu / Alvis Brazma / Zhichao Miao

    Scientific Reports, Vol 11, Iss 1, Pp 1-

    2021  Volume 10

    Abstract: Abstract Several single-cell RNA sequencing (scRNA-seq) studies analyzing immune response to COVID-19 infection have been recently published. Most of these studies have small sample sizes, which limits the conclusions that can be made with high ... ...

    Abstract Abstract Several single-cell RNA sequencing (scRNA-seq) studies analyzing immune response to COVID-19 infection have been recently published. Most of these studies have small sample sizes, which limits the conclusions that can be made with high confidence. By re-analyzing these data in a standardized manner, we validated 8 of the 20 published results across multiple datasets. In particular, we found a consistent decrease in T-cells with increasing COVID-19 infection severity, upregulation of type I Interferon signal pathways, presence of expanded B-cell clones in COVID-19 patients but no consistent trend in T-cell clonal expansion. Overall, our results show that the conclusions drawn from scRNA-seq data analysis of small cohorts of COVID-19 patients need to be treated with some caution.
    Keywords Medicine ; R ; Science ; Q
    Language English
    Publishing date 2021-10-01T00:00:00Z
    Publisher Nature Portfolio
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  10. Article ; Online: Real-world effectiveness and safety of ustekinumab and vedolizumab in elderly patients with Crohn's disease.

    Garg, Rajat / Aggarwal, Manik / Mohammed, Abdul / Achkar, Jean Paul / Lashner, Bret / Philpott, Jessica / Cohen, Benjamin / Qazi, Taha / Rieder, Florian / Regueiro, Miguel / Click, Benjamin

    Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology

    2023  Volume 42, Issue 5, Page(s) 718–723

    Abstract: Studies report favorable efficacy and safety profiles of ustekinumab (UST) and vedolizumab (VDZ) in Crohn's disease (CD), but effectiveness and safety data in elderly patients with CD is lacking. We retrospectively analyzed 78 elderly patients (39 each ... ...

    Abstract Studies report favorable efficacy and safety profiles of ustekinumab (UST) and vedolizumab (VDZ) in Crohn's disease (CD), but effectiveness and safety data in elderly patients with CD is lacking. We retrospectively analyzed 78 elderly patients (39 each UST and VDZ) and found that patients on UST and VDZ experienced similar rates of clinical response, remission and mucosal healing despite high proportion of prior biologic exposure. Both UST and VDZ appear to be effective and safe in this at-risk CD population. Further large studies are needed to validate our findings.
    MeSH term(s) Humans ; Aged ; Crohn Disease/drug therapy ; Ustekinumab/adverse effects ; Retrospective Studies ; Antibodies, Monoclonal, Humanized/adverse effects ; Treatment Outcome ; Remission Induction
    Chemical Substances Ustekinumab (FU77B4U5Z0) ; vedolizumab (9RV78Q2002) ; Antibodies, Monoclonal, Humanized
    Language English
    Publishing date 2023-07-31
    Publishing country India
    Document type Journal Article
    ZDB-ID 632595-6
    ISSN 0975-0711 ; 0254-8860
    ISSN (online) 0975-0711
    ISSN 0254-8860
    DOI 10.1007/s12664-023-01391-3
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top